A Virtual Event | May 4-6, 2021

The 2nd Annual event will be coming to Washington, DC on May 23-24, 2022. Check back again soon for more details.

The Psychedelic Therapeutics and Drug Development Conference has been organized to bring together the world’s leading researchers and leaders in academia and industry to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.

MAILING LIST

SPEAKING OPPORTUNITIES

REQUEST BROCHURE

Conference Themes

Clinical trial design
Risk Evaluation & Mitigation Strategy (REMS)
Abuse potential
Practical use/indications/
DEA licensure & policy considerations

Targets for novel drug development
Dosage (micro/low/high)
Second generation psychedelic drug design
FDA regulatory guidance
Toxicology studies and considerations

Featured Speakers

Bryan Roth, MD, Ph.D.Michael Hooker Distinguished Professor

University of North Carolina School of Medicine

Charles Nichols, Ph.D.Professor, Department of Pharmacology & Experimental Therapeutics

LSU Health Sciences Center

See the Full Speaking Faculty

Frederick Barrett, Ph.D.Assistant Professor of Psychiatry & Behavioral Sciences

Johns Hopkins School of Medicine

Reasons to Attend

Discover & Learn

Learn about the latest developments in the field of psychedelics research and better understand the path forward for clinical development.

Meet, Network & Re-connect

Utilize our mobile and web-based platforms to meet and network with colleagues before, during and after the event.

Navigate Regulatory & Policy Challenges

Learn about and navigate the regulatory and policy challenges facing developers of psychedelic-based therapies.

Who Should Attend

Chief Executive Officers
Vice Presidents
Chief Medical Officers
Business Development Professionals
Regulatory Affairs Professionals
Research Scientists
R&D Professionals
Clinical Development Professionals

Licensing Professionals
Investigators
Medical Chemists
Chemists
Pharmacists
Scientists
Study Managers
Project Managers

Scientific Officers
Professors
Ph.D./Pharm.D. Students
Health Care Practitioners
Program Officers
Investors
Analysts
Medical Directors